Gene · 6012
Papers2,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting androgen receptor (AR) with a synthetic peptide increases apoptosis in triple negative breast cancer and AR-expressing prostate cancer cell lines. | Cancer Rep (Hoboken) | 2024 | 37903548 | PubTator, text mining | PubMed |
| [Pulmonary involvement in idiopathic inflammatory myopathies]. | Pneumologie | 2024 | 37647917 | PubTator, text mining | PubMed |
| High-Throughput Screening to Advance In Vitro Toxicology: Accomplishments, Challenges, and Future Directions. | Annu Rev Pharmacol Toxicol | 2024 | 37506331 | PubTator, text mining | PubMed |
| Differences in muscle magnetic resonance imaging findings between anti-signal recognition particle antibody-positive myopathy and anti-aminoacyl-tRNA synthetase antibody-positive myositis. | Clin Exp Rheumatol | 2024 | 37497714 | PubTator, text mining | PubMed |
| AndroPred: an artificial intelligence-based model for predicting androgen receptor inhibitors. | J Biomol Struct Dyn | 2024 | 37493402 | PubTator, text mining | PubMed |
Structural Landscape of nsp Coding Genomic Regions of SARS-CoV-2-ssRNA Genome: A Structural Genomics Approach Toward Identification of Druggable Genome, Ligand-Binding Pockets, and Structure-Based Druggability. | Mol Biotechnol | 2024 | 36463562 | PubTator, text mining | PubMed |
| Unusual Manifestation of Dermatomyositis: Exacerbation of Hypertriglyceridemia. | Cureus | 2023 | 38283441 | PubTator, text mining | PubMed |
| Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response. | Biomolecules | 2023 | 38275742 | PubTator, text mining | PubMed |
| Progressive pulmonary fibrosis in myositis-specific antibody-positive interstitial pneumonia: a retrospective cohort study. | Front Med (Lausanne) | 2023 | 38274458 | PubTator, text mining | PubMed |
| Genetics of the anterior segment dysgenesis. | Taiwan J Ophthalmol | 2023 | 38249510 | PubTator, text mining | PubMed |
| Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology. | Front Pharmacol | 2023 | 38235113 | PubTator, text mining | PubMed |
| Androgen Receptor in Hormone Receptor-Positive Breast Cancer. | Int J Mol Sci | 2023 | 38203649 | PubTator, text mining | PubMed |
| Efficacy of mirabegron for ureteral stones: a systematic review with meta-analysis of randomized controlled trials. | Front Pharmacol | 2023 | 38178860 | PubTator, text mining | PubMed |
| Umbelliferone and Its Synthetic Derivatives as Suitable Molecules for the Development of Agents with Biological Activities: A Review of Their Pharmacological and Therapeutic Potential. | Pharmaceuticals (Basel) | 2023 | 38139858 | PubTator, text mining | PubMed |
| Synephrine and Its Derivative Compound A: Common and Specific Biological Effects. | Int J Mol Sci | 2023 | 38139366 | PubTator, text mining | PubMed |
| Is the β3-Adrenoceptor a Valid Target for the Treatment of Obesity and/or Type 2 Diabetes? | Biomolecules | 2023 | 38136585 | PubTator, text mining | PubMed |
| Androgen Receptor Expression in ER and PR Negative Breast Cancer-A Study from a Tertiary Hospital in Northern India. | South Asian J Cancer | 2023 | 38130277 | PubTator, text mining | PubMed |
| Anti-EJ antibody-positive interstitial pneumonia with breast cancer improved by combining immunosuppressive therapy and chemotherapy. | Respir Med Case Rep | 2023 | 38124994 | PubTator, text mining | PubMed |
| 2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A1 Adenosine Receptor Positive Allosteric Modulators. | ACS Med Chem Lett | 2023 | 38116442 | PubTator, text mining | PubMed |
| Elucidating arsenic-bound proteins in the protein data bank: data mining and amino acid cross-validation through Raman spectroscopy. | RSC Adv | 2023 | 38090090 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6012/papers?page=12